
	Where results make sense

Topic: Mycosis

Related Topics

Skin

Disease

Enterobiasis

Human biology

Fungus

Fistula

Sweat gland

Exocrine gland

Microbe

Excretory system

Pinworm

Bromhidrosis

Aspergillus niger

Anhidrosis

Endocrine system

In the News (Mon 13 Feb 12)

EXECUTIVE POWER

Iran

ANALYSIS

Pakistan

Family compact

	Mycosis fungoides
		In reality, mycosis fungoides is unrelated to fungus and the fungoides portion derives from a patient with a severe case whom Alibert described as having mushroom-like skin tumors.
		The cause of mycosis fungoides is unknown, and is not believed to be hereditary or genetic.
		Mycosis fungoides can be treated in a variety of ways, and if treatment is successful the disease can go into a non-progressing state called remission, which can last indefinitely.
	www.mrsci.com /Hematology/Mycosis_fungoides.php (289 words)

	Mycosis Fungoides/Sézary Syndrome Treatment - National Cancer Institute
		Mycosis fungoides and the SÃ©zary syndrome are diseases in which lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin.
		It is hard to diagnose the rash as mycosis fungoides during this phase.
		Mycosis fungoides and the SÃ©zary syndrome are difficult to cure.
	www.cancer.gov /cancerinfo/pdq/treatment/mycosisfungoides/patient (897 words)

	mycosis - British Association of Dermatologists (Site not responding. Last check: 2007-10-07)
		The name ‘mycosis fungoides’ is a bad one: it was coined 200 years ago and hints, quite wrongly, that mycosis fungoides is some sort of fungal infection.
		Mycosis fungoides is rare and, for many sufferers, it does not affect the quality of life or life expectancy.
		Mycosis fungoides can occur at any age but it is most common in the 40-60 year old age group.
	www.bad.org.uk /patients/leaflets/mycosis.asp (727 words)

	Sezary Syndrome/Mycosis Fungoides
		Mycosis fungoides and the Sezary syndrome (MF/SS) are neoplasias of malignant T-lymphocytes that usually possess the helper/inducer cell surface phenotype.
		Peripheral blood involvement with mycosis fungoides or Sezary cells is correlated with more advanced skin stage, lymph node and visceral involvement, and shortened survival, but probably provides no independent prognostic information beyond that associated with TNM staging.
		Fludarabine, 2-chlorodeoxyadenosine, and pentostatin are active agents for mycosis fungoides and Sezary syndrome.[6-9] 5.
	www.medhelp.org /lib/cancernet/110830.htm (4843 words)

	Mycosis fungoides - treatment of mycosis fungoides (Site not responding. Last check: 2007-10-07)
		Mycosis Fungoides, also known as Alibert-Bazin syndrome mycosis fungoides and bony growths or granuloma fungoides, is a rare form of non-Hodgkin's lymphoma.
		The cause bone spurs with mycosis fungoides of mycosis fungoides is unknown, and is not believed to be hereditary or genetic.
		Mycosis fungoides can be treated in a variety of ways, and if treatment is successful treatment length for mycosis fungoides the disease can go into a non-progressing state called remission, which can last indefinitely.
	www.medicalgeo.com /Med-Diseases-My---O/Mycosis-fungoides.html (430 words)

	Mycosis Fungoides and the Sézary Syndrome: (Site not responding. Last check: 2007-10-07)
		After mycosis fungoides and the Sézary syndrome have been diagnosed, tests are done to find out if cancer cells have spread from the skin to other parts of the body.
		Mycosis fungoides and the Sézary syndrome are diseases in which lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin.
		Recurrent mycosis fungoides and the Sézary syndrome are cancers that have recurred (come back) after they have been treated.
	www.acor.org /cnet/258022.html (3585 words)

	Mycosis fungoides
		It is a rare clinical form of patch-stage mycosis fungoides characterized by generalized poikiloderma, atrophy, mottled dyspigmentation, and telangiectases.
		Mycosis fungoides is a malignant neoplasm of T-lymphocyte origin, most commonly a memory CD4+ T cell.
		Poikiloderma vasculare atrophicans (parapsoriasis variegata) represents a variant of mycosis fungoides that is characterized by generalized poikiloderma, atrophy, mottled dyspigmentation, and telangectases [1].
	dermatology.cdlib.org /94/NYU/Mar2002/6.html (509 words)

	Cutaneous T-cell lymphoma. DermNet NZ
		Mycosis fungoides is the most common type of CTCL and accounts for almost 50% of all primary cutaneous lymphomas.
		Mycosis fungoides is a condition in which the skin is infiltrated by patches or lumps composed of white cells called lymphocytes.
		Mycosis fungoides has an indolent (low-grade) clinical course, which means that it may persist in one stage or over years or sometimes decades, slowly progress to another stage (from patches to thicker plaques and eventually to tumours).
	dermnetnz.org /dermal-infiltrative/cutaneous-t-cell-lymphoma.html (1110 words)

	Mycosis Fungoides
		Mycosis Fungoides is a rare form of T-cell lymphoma of the skin (cutaneous); the disease is typically slowly progressive and chronic.
		In individuals with Mycosis Fungoides, the skin becomes infiltrated with plaques and nodules that are composed of lymphocytes.
		A diagnosis of Mycosis Fungoides may be made by a thorough clincial evaluation and a variety of specialized techniques and tests including DNA cytophotometry, nuclear contour analysis, and analysis of T-cell receptor gene rearrangement.
	hw.healthdialog.com /kbase/nord/nord458.htm (1786 words)

	Mycosis Fungoides and the Sézary Syndrome: (Site not responding. Last check: 2007-10-07)
		Mycosis fungoides and the Sézary syndrome is a disease in which certain cells of the lymph system (called T-lymphocytes) become cancer (malignant) and affect the skin.
		Mycosis fungoides and the Sézary syndrome usually develops slowly over many years.
		Once mycosis fungoides and the Sézary syndrome is found, more tests will be done to find out if cancer cells have spread to other parts of the body.
	www.acor.org /cnet/62882.html (2479 words)

	Mycosis fungoides and the sezary syndrome: Treatment - Health Professional Information [NCI PDQ] -- General Information
		Mycosis fungoides and the Sézary syndrome (MF/SS) are neoplasias of malignant T-lymphocytes that usually possess the helper/inducer cell surface phenotype.
		Cytologic transformation from a low-grade lymphoma to a high-grade lymphoma sometimes occurs during the course of these diseases and is associated with a poor prognosis.[10,11,12] A common cause of death during the tumor phase is sepsis from Pseudomonas aeruginosa or Staphylococcus aureus caused by chronic skin infection with staph species and subsequent systemic infections.[9]
		Kim YH, Bishop K, Varghese A, et al.: Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
	www.webmd.com /hw/cancer/ncicdr0000062881-general-information.asp (660 words)

	Arch Dermatol -- Mycosis Fungoides Bullosa, June 2006, Natsuga et al. 142 (6): 793
		Arch Dermatol -- Mycosis Fungoides Bullosa, June 2006, Natsuga et al.
		Mycosis fungoides (MF), a cutaneous lymphoma with diverse clinical
		A, Dark reddish macules on the trunk corresponding with typical mycosis fungoides.
	archderm.ama-assn.org /cgi/content/short/142/6/793?rss=1 (134 words)

	TomsMFCTCLpage
		Because early mycosis fungoides can mimic so many common skin diseases, a series of skin biopsies may be necessary that are then read by a experienced dermatopathologist who can then determine if there is a definitive diagnosis of mycosis fungoides.
		Mycosis fungoides is usually an indolent (slow growing) cancer, but in rare cases may become aggressive.
		While the older medical literature was often pessimistic about a diagnosis of mycosis fungoides, today this same diagnosis may be viewed in a more positive manner, with MF often being a more manageable disease for all stages and sometimes even curable (achieving a durable remission) with early stage disease.
	tomsmfctclpage.homestead.com /index.html (1983 words)

	Mycosis Fungoides Treatment and Prognosis
		Although the excess of lymphoma may be related to the evolution of CTCL to less differentiated T-cell lymphoma, additional studies are needed to clarify the immunologic, genetic, viral, and environmental factors that may contribute to the development of second cancers.
		Progression of mycosis fungoides is associated with Th(2) cytokines produced by a clonal proliferation of epidermotropic T-helper cells.
		Treatment of mycosis fungoides has encompassed a variety of modalities including the use of retinoids with several studies evaluating their efficacy.
	www.thedoctorsdoctor.com /diseases/mycosis_fungoides_tx.htm (10136 words)

	Mycosis fungoides - Wikipedia, the free encyclopedia
		It is rare for the disease to appear before age 20, and it appears to be noticeably more common in males than females, especially over the age of 50, where the incidence of the disease (the risk per person in the population) does increase.
		Mycosis Fungoides is the most common type of 'Cutaneous T-cell Lymphoma' (CTCL), but there are many other types of CTCL that have nothing to do with Mycosis Fungoides and these disorders are treated differently.
		To stage the disease, various tests may be ordered, to assess nodes, blood and internal organs, but most patients present with disease apparently confined to the skin, as patches (flat spots) and plaques (slightly raised or 'wrinkled' spots).
	en.wikipedia.org /wiki/Mycosis_fungoides (662 words)

	Mycosis fungoides
		We hypothesized that hypomelanosis in hypopigmented mycosis fungoides may have a similar mechanism as in vitiligo, a condition in which it is believed that alterations in expression of CD117 (stem cell factor receptor/KIT protein) on epidermal melanocytes and abnormal interactions between melanocytes and surrounding keratinocytes may play a pathogenic role.
		Reassessment of histologic parameters in the diagnosis of mycosis fungoides
		Thirty cases of mycosis fungoides and 30 cases of spongiotic dermatitis were retrieved from archival hematoxylin and eosin-stained histologic sections.
	www.thedoctorsdoctor.com /diseases/mycosis_fungoides.htm (13216 words)

	Mycosis fungoides and the sezary syndrome: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics ... (Site not responding. Last check: 2007-10-07)
		The histologic diagnosis of mycosis fungoides and the Sézary syndrome (MF/SS) is usually difficult to determine in the initial stages of the disease and may require the review of multiple biopsies by an experienced pathologist.
		Peripheral blood involvement with mycosis fungoides or Sézary syndrome (MF/SS) cells is correlated with more advanced skin stage, lymph node and visceral involvement, and shortened survival but probably provides no independent prognostic information beyond that associated with TNM staging.
		Rosen ST, Foss FM: Chemotherapy for mycosis fungoides and the Sézary syndrome.
	www.questdiagnostics.com /kbase/nci/ncicdr0000062881.htm (5585 words)

	Mycosis Fungoides and the Sézary Syndrome
		Different types of treatment are available for patients with mycosis fungoides and the Sézary syndrome.
		Treatment of stage II mycosis fungoides and the Sézary syndrome is palliative and may include the following:
		Treatment of stage IV mycosis fungoides and the Sézary syndrome is palliative and may include the following:
	www.meb.uni-bonn.de /cancer.gov/CDR0000258022.html (3251 words)

	Mycosis fungoides - WrongDiagnosis.com
		Mycosis fungoides is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH).
		This means that Mycosis fungoides, or a subtype of Mycosis fungoides, affects less than 200,000 people in the US population.
		With a diagnosis of Mycosis fungoides, it is also important to consider whether there is an underlying condition causing Mycosis fungoides.
	www.wrongdiagnosis.com /m/mycosis_fungoides/intro.htm (896 words)

	Mycosis fungoides/Sezary syndrome
		Mycosis fungoides and the Sezary syndrome is a disease in which certain cells of the lymph system (called T-lymphocytes) become cancer (malignant) and affect the skin.
		Stages of mycosis fungoides and the Sezary syndrome
		Once mycosis fungoides and the Sezary syndrome is found, more tests will be done to find out if cancer cells have spread to other parts of the body.
	cancerweb.ncl.ac.uk /cancernet/210830.html (2444 words)

	Caring Medical - Symptoms - Mycosis Fungoides
		Mycosis fungoides, also called cutaneous t-cell lymphoma, is a type of lymphoma.
		Mycosis fungoides is more common among men than women, as well as after the age of 50.
		Being diagnosed with cancer, such as mycosis fungoides, can be a very sobering and frightening experience.
	www.caringmedical.com /conditions/Mycosis_Fungoides.htm (413 words)

	Community - Multidisciplinary Cutaneous Lymphoma Group - Stanford University School of Medicine
		No. There is no evidence that Mycosis Fungoides can be transmitted by touch, saliva, blood, or other bodily fluids.
		There is a possibility your offspring may develop Mycosis Fungoides if it is clearly established that your family has a history of familial Mycosis Fungoides.
		We have reviewed the data of the patients seen in our Multidisciplinary Cutaneous Lymphoma Clinic for the past 50 years here at Stanford, and the risk of your condition becoming worse is correlated to the extent of your skin disease and response to therapy.
	cutaneouslymphoma.stanford.edu /community/com_faq_glossary.html (1091 words)

	Mycosis fungoides and the sezary syndrome: Treatment - Health Professional Information [NCI PDQ]
		Foss FM, Ihde DC, Breneman DL, et al.: Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
		Herrmann JJ, Roenigk HH Jr, Hurria A, et al.: Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
		Foss FM, Ihde DC, Linnoila IR, et al.: Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
	www.peacehealth.org /kbase/nci/ncicdr0000062881.htm (5579 words)

	Non-Aspergillus Allergic Bronchopulmonary Mycosis in a Pediatric Patient With Cystic Fibrosis -- Gondor et al. 102 (6): ...
		of oral prednisone for presumed allergic bronchopulmonary mycosis.
		Knutsen A, Slavin RG Allergic bronchopulmonary mycosis complicating cystic fibrosis.
		Brueton MJ, Ormerod LP, Shah KJ, Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood.
	pediatrics.aappublications.org /cgi/content/full/102/6/1480 (1688 words)

	JAMA -- Abstract: Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology, July 1, ...
		The etiology of mycosis fungoides is obscure, and the risk factors for its
		mycosis fungoides was noted over the period of this study.
		Mycosis Fungoides: Disease Evolution and Prognosis of 309 Dutch Patients
	jama.ama-assn.org /cgi/content/abstract/260/1/42 (285 words)

	A profile of mycosis fungoides -- Dorfman 102 (3): 778 -- Blood
		Mycosis fungoides is the most common primary lymphoproliferative
		analysis on 29 cases of mycosis fungoides and 11 cases of inflammatory
		between mycosis fungoides and inflammatory conditions in 97%
	www.bloodjournal.org /cgi/content/full/102/3/778 (344 words)

	Comparison of Mycosis IC/F and Plus Aerobic/F Media for Diagnosis of Fungemia by the Bactec 9240 System -- Meyer et al. ...
		Mycosis IC/F medium is a brain-heart broth enriched with sucrose,
		duration was 160 h for the Mycosis IC/F vials and 120 h for
		Mycosis IC/F medium, when analyzed both by sample and by patient.
	jcm.asm.org /cgi/content/full/42/2/773 (2749 words)

	Clinical Characteristics and Outcome of Patients With Extracutaneous Mycosis Fungoides -- de Coninck et al. 19 (3): 779 ...
		MYCOSIS FUNGOIDES (MF) is a malignant lymphoproliferative T-cell
		Weinstock MA, Horm JW: Population-based estimate of survival and determinants of prognosis in patients with mycosis fungoides.
		Weinstock MA, Reynes JF: The changing survival of patients with mycosis fungoides: A population-based assessment of trends in the United States.
	www.jco.org /cgi/content/full/19/3/779 (3102 words)

	eMedicine - Mycosis Fungoides : Article by Lauren C Pinter-Brown, MD
		CTCL was used to describe a heterogenous group of malignant T-cell lymphomas with primary manifestations in the skin.
		Early in the course of mycosis fungoids (MF) as well as in erythrodermic cases, skin lesions may be nonspecific, with a nondiagnostic biopsy result, so confusion with benign conditions is common.
		Kim YH, Hoppe RT: Mycosis fungoides and the Sezary syndrome.
	www.emedicine.com /med/topic1541.htm (3520 words)

Try your search on: Qwika (all wikis)